Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach-Reference-Cited by-同舟云学术

Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach

Published:2015-07-28 Issue:7 Volume:10 Page:e0134174
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lin Guigao,Yi Lang,Zhang Kuo,Wang Lunan,Zhang Rui,Xie Jiehong,Li Jinming

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference18 articles.

1. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;FG Kushner;J Am Coll Cardiol,2009

2. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite;M Kazui;Drug Metab Dispos,2010

3. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy;AR Shuldiner;JAMA,2009

4. The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance;KA Kim;Clin Pharmacol Ther,2008

5. Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy;K Yamamoto;J Cardiol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for Antiplatelet Therapy;Biomarkers in Cardiovascular Disease;2019

2. Quality control materials for pharmacogenomic testing in the clinic;Clinical Chemistry and Laboratory Medicine (CCLM);2017-01-01

3. Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre;Archivum Immunologiae et Therapiae Experimentalis;2016-12

4. National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China;PLOS ONE;2016-09-07